A photo of Brian Turpin.

Member, Division of Oncology

Assistant Professor, UC Department of Pediatrics

513-517-2234

513-636-3549

Board Certified

My Biography & Research

Biography

Brian K. Turpin, DO, completed his undergraduate training at the University of Missouri, graduate medical training at the Kansas City University of Medicine and Biosciences, and pediatric residency and hematology / oncology fellowship at Cincinnati Children’s Hospital Medical Center where he served as co-chief fellow. 

Dr. Turpin’s clinical and academic interests pertain to children and young adults with solid tumors, particularly sarcomas and neuroblastomas, with a research focus on the development of new drugs and clinical trials for patients with relapsed cancer.

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Clinical Divisions

Cancer and Blood Diseases, Sarcoma, Neuroblastoma

Research Divisions

Oncology

My Locations

My Education

DO: Kansas City University of Medicine and Biosciences.

Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center.

Fellowship: Pediatric Hematology / Oncology, Cincinnati Children’s Hospital Medical Center, Cancer and Blood Diseases Institute.

My Publications

Reply to comment on: Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations. Turpin, B; Todd, KE; Pressey, JG. Pediatric Blood and Cancer. 2020; 67.

Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations. Todd, K; Kim, HK; Szabo, S; Johnson, S; Pressey, J; Nagarajan, R; Sorger, J; Dasgupta, R; Turpin, B. Pediatric Blood and Cancer. 2020; 67.

Can a children's hospital still cut it? Comparing outcomes of pediatric, adolescent and young adult patients undergoing thoracic surgery for lung metastases. Scorletti, F; Cooke-Barber, J; Pressey, JG; Nagarajan, R; Turpin, B; Jenkins, T; Dasgupta, R. Pediatric Blood and Cancer. 2020; 67.

Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung. Baird, K; Glod, J; Steinberg, SM; Reinke, D; Pressey, JG; Mascarenhas, L; Federman, N; Marina, N; Chawla, S; Lagmay, JP; et al. Sarcoma. 2020; 2020:1-6.

Paediatric ganciclovir dosing in extracorporeal membrane oxygenation: Is standard dosing good enough?. Murphy, M; Chamberlain, A; Tang, P; Turpin, B; Danziger-Isakov, L. Journal of Clinical Pharmacy and Therapeutics. 2020; 45:218-220.

Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al. Pediatric Blood and Cancer. 2019; 66.

Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma. Seligson, ND; Awasthi, A; Millis, SZ; Turpin, BK; Meyer, CF; Grand'Maison, A; Liebner, DA; Hays, JL; Chen, JL. JAMA Network Open. 2019; 2:e1912416-e1912416.

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016). Widemann, BC; Lu, Y; Reinke, D; Okuno, SH; Meyer, CF; Cote, GM; Chugh, R; Milhem, MM; Hirbe, AC; Kim, A; et al. Sarcoma. 2019; 2019:1-8.

Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors. Davis, JL; Lockwood, CM; Stohr, B; Boecking, C; Al-Ibraheemi, A; DuBois, SG; Vargas, SO; Black, JO; Cox, MC; Luquette, M; et al. American Journal of Surgical Pathology. 2019; 43:435-445.

Sentinel lymph node biopsy in head and neck rhabdomyosarcoma. Turpin, B; Pressey, JG; Nagarajan, R; Weiss, BD; Trout, AT; Gelfand, MJ; Pater, L; Vatner, RE; Breneman, JC; Dasgupta, R. Pediatric Blood and Cancer. 2019; 66:e27532-e27532.